Ann: RHY Welcomes Leading Biotech Fund as New Major Shareholder, page-3

Indeed. 5.02% of the company at an average of 19.15cps. Bodes well for a material rerate from these levels...

	Column 1	Column 2	Column 3
0	2,100,000	$ 378,832	$ 0.1804
1	400,000	$ 76,251	$ 0.1906
2	2,481,567	$ 497,405	$ 0.2004
3	78,433	$ 16,581	$ 0.2114
4	5,060,000	$ 969,069	$ 0.1915

Good to see a long term investor locking up 10% of free float. Especially one with such a strong tack record:

	Column 1	Column 2	Column 3	Column 4
0	Fund Performance as at 30 June 2017
1		1 Year	2 Year	3 Year
2	Merchant Opportunities Fund (Ex EPF)	21.21%	55.23%	32.87%
3	ASX 200 Non-Accum Index	9.33%	2.60%	2.13%
4	All Ordinaries Non-Accum Index	8.55%	2.98%	2.41%

Source: https://www.merchantfunds.com.au/about/